nodes	percent_of_prediction	percent_of_DWPC	metapath
Darunavir—CYP3A4—Rifampicin—leprosy	0.262	0.548	CbGbCtD
Darunavir—CYP3A4—Dapsone—leprosy	0.216	0.452	CbGbCtD
Darunavir—Hypoalbuminaemia—Dapsone—leprosy	0.0324	0.0622	CcSEcCtD
Darunavir—Toxic skin eruption—Thalidomide—leprosy	0.025	0.0479	CcSEcCtD
Darunavir—Creatinine low—Thalidomide—leprosy	0.0189	0.0363	CcSEcCtD
Darunavir—Blood creatinine decreased—Thalidomide—leprosy	0.0173	0.0332	CcSEcCtD
Darunavir—Swelling face—Dapsone—leprosy	0.0149	0.0285	CcSEcCtD
Darunavir—Lipase increased—Thalidomide—leprosy	0.0123	0.0237	CcSEcCtD
Darunavir—Autoimmune disorder—Thalidomide—leprosy	0.0109	0.0208	CcSEcCtD
Darunavir—Proteinuria—Dapsone—leprosy	0.00806	0.0155	CcSEcCtD
Darunavir—Protein urine present—Dapsone—leprosy	0.00795	0.0152	CcSEcCtD
Darunavir—Altered state of consciousness—Thalidomide—leprosy	0.00785	0.0151	CcSEcCtD
Darunavir—Aphthous stomatitis—Thalidomide—leprosy	0.00773	0.0148	CcSEcCtD
Darunavir—Grand mal convulsion—Thalidomide—leprosy	0.00762	0.0146	CcSEcCtD
Darunavir—Sinus bradycardia—Thalidomide—leprosy	0.00739	0.0142	CcSEcCtD
Darunavir—Transient ischaemic attack—Thalidomide—leprosy	0.00719	0.0138	CcSEcCtD
Darunavir—Hypothyroidism—Thalidomide—leprosy	0.00565	0.0108	CcSEcCtD
Darunavir—Seborrhoeic dermatitis—Thalidomide—leprosy	0.00532	0.0102	CcSEcCtD
Darunavir—Hepatomegaly—Thalidomide—leprosy	0.00512	0.00982	CcSEcCtD
Darunavir—Hyperlipidaemia—Thalidomide—leprosy	0.00503	0.00965	CcSEcCtD
Darunavir—Cholestasis—Thalidomide—leprosy	0.00477	0.00916	CcSEcCtD
Darunavir—Nasopharyngitis—Dapsone—leprosy	0.0046	0.00882	CcSEcCtD
Darunavir—Muscular weakness—Dapsone—leprosy	0.00453	0.0087	CcSEcCtD
Darunavir—Endocrine disorder—Thalidomide—leprosy	0.00437	0.00839	CcSEcCtD
Darunavir—Pancreatitis—Dapsone—leprosy	0.00436	0.00835	CcSEcCtD
Darunavir—Proteinuria—Thalidomide—leprosy	0.00413	0.00791	CcSEcCtD
Darunavir—Protein urine present—Thalidomide—leprosy	0.00407	0.0078	CcSEcCtD
Darunavir—Musculoskeletal stiffness—Thalidomide—leprosy	0.00404	0.00775	CcSEcCtD
Darunavir—Hyperbilirubinaemia—Thalidomide—leprosy	0.00399	0.00765	CcSEcCtD
Darunavir—Hypocalcaemia—Thalidomide—leprosy	0.00396	0.00759	CcSEcCtD
Darunavir—Herpes simplex—Thalidomide—leprosy	0.00393	0.00754	CcSEcCtD
Darunavir—Hyperuricaemia—Thalidomide—leprosy	0.00391	0.0075	CcSEcCtD
Darunavir—Drug interaction—Thalidomide—leprosy	0.00391	0.0075	CcSEcCtD
Darunavir—Neuropathy peripheral—Dapsone—leprosy	0.00388	0.00745	CcSEcCtD
Darunavir—Hypercholesterolaemia—Thalidomide—leprosy	0.00383	0.00735	CcSEcCtD
Darunavir—Blood uric acid increased—Thalidomide—leprosy	0.00369	0.00708	CcSEcCtD
Darunavir—Hyperkalaemia—Thalidomide—leprosy	0.00356	0.00683	CcSEcCtD
Darunavir—Eructation—Thalidomide—leprosy	0.00356	0.00683	CcSEcCtD
Darunavir—Dry eye—Thalidomide—leprosy	0.00335	0.00642	CcSEcCtD
Darunavir—Rash maculo-papular—Thalidomide—leprosy	0.0033	0.00632	CcSEcCtD
Darunavir—Gynaecomastia—Thalidomide—leprosy	0.00324	0.00622	CcSEcCtD
Darunavir—Sepsis—Thalidomide—leprosy	0.00315	0.00603	CcSEcCtD
Darunavir—Erythema—Dapsone—leprosy	0.0031	0.00594	CcSEcCtD
Darunavir—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.00303	0.0058	CcSEcCtD
Darunavir—Diabetes mellitus—Thalidomide—leprosy	0.00303	0.0058	CcSEcCtD
Darunavir—Eczema—Thalidomide—leprosy	0.00293	0.00562	CcSEcCtD
Darunavir—Renal failure acute—Thalidomide—leprosy	0.00285	0.00547	CcSEcCtD
Darunavir—Libido decreased—Thalidomide—leprosy	0.00284	0.00544	CcSEcCtD
Darunavir—Increased appetite—Thalidomide—leprosy	0.0028	0.00537	CcSEcCtD
Darunavir—Vertigo—Dapsone—leprosy	0.00278	0.00533	CcSEcCtD
Darunavir—Visual disturbance—Thalidomide—leprosy	0.00278	0.00533	CcSEcCtD
Darunavir—Arthritis—Thalidomide—leprosy	0.00271	0.00519	CcSEcCtD
Darunavir—Cough—Dapsone—leprosy	0.0027	0.00518	CcSEcCtD
Darunavir—Hypoglycaemia—Thalidomide—leprosy	0.0027	0.00517	CcSEcCtD
Darunavir—Cerebrovascular accident—Thalidomide—leprosy	0.00269	0.00515	CcSEcCtD
Darunavir—Lethargy—Thalidomide—leprosy	0.00269	0.00515	CcSEcCtD
Darunavir—Hyponatraemia—Thalidomide—leprosy	0.00264	0.00507	CcSEcCtD
Darunavir—Pain in extremity—Thalidomide—leprosy	0.00263	0.00505	CcSEcCtD
Darunavir—Disturbance in sexual arousal—Thalidomide—leprosy	0.00261	0.00501	CcSEcCtD
Darunavir—Affect lability—Thalidomide—leprosy	0.00259	0.00497	CcSEcCtD
Darunavir—Mood swings—Thalidomide—leprosy	0.00249	0.00478	CcSEcCtD
Darunavir—Tachycardia—Dapsone—leprosy	0.00247	0.00473	CcSEcCtD
Darunavir—Blood creatinine increased—Thalidomide—leprosy	0.00247	0.00473	CcSEcCtD
Darunavir—Liver function test abnormal—Thalidomide—leprosy	0.00243	0.00466	CcSEcCtD
Darunavir—Dry skin—Thalidomide—leprosy	0.00241	0.00463	CcSEcCtD
Darunavir—Breast disorder—Thalidomide—leprosy	0.00238	0.00456	CcSEcCtD
Darunavir—Toxic epidermal necrolysis—Thalidomide—leprosy	0.00237	0.00454	CcSEcCtD
Darunavir—Aspartate aminotransferase increased—Thalidomide—leprosy	0.00237	0.00454	CcSEcCtD
Darunavir—Muscular weakness—Thalidomide—leprosy	0.00232	0.00445	CcSEcCtD
Darunavir—Alanine aminotransferase increased—Thalidomide—leprosy	0.00232	0.00445	CcSEcCtD
Darunavir—Abdominal distension—Thalidomide—leprosy	0.00229	0.00439	CcSEcCtD
Darunavir—Insomnia—Dapsone—leprosy	0.00229	0.00438	CcSEcCtD
Darunavir—Eosinophilia—Thalidomide—leprosy	0.00225	0.00432	CcSEcCtD
Darunavir—Pancreatitis—Thalidomide—leprosy	0.00223	0.00428	CcSEcCtD
Darunavir—Angina pectoris—Thalidomide—leprosy	0.00222	0.00425	CcSEcCtD
Darunavir—Pancytopenia—Thalidomide—leprosy	0.00216	0.00414	CcSEcCtD
Darunavir—Neutropenia—Thalidomide—leprosy	0.00213	0.00408	CcSEcCtD
Darunavir—Pollakiuria—Thalidomide—leprosy	0.0021	0.00403	CcSEcCtD
Darunavir—Erectile dysfunction—Thalidomide—leprosy	0.0021	0.00402	CcSEcCtD
Darunavir—Weight increased—Thalidomide—leprosy	0.00207	0.00397	CcSEcCtD
Darunavir—Gastrointestinal pain—Dapsone—leprosy	0.00207	0.00396	CcSEcCtD
Darunavir—Weight decreased—Thalidomide—leprosy	0.00206	0.00395	CcSEcCtD
Darunavir—Hyperglycaemia—Thalidomide—leprosy	0.00205	0.00393	CcSEcCtD
Darunavir—Infestation—Thalidomide—leprosy	0.00203	0.00389	CcSEcCtD
Darunavir—Infestation NOS—Thalidomide—leprosy	0.00203	0.00389	CcSEcCtD
Darunavir—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00201	0.00386	CcSEcCtD
Darunavir—Acute coronary syndrome—Thalidomide—leprosy	0.002	0.00383	CcSEcCtD
Darunavir—Abdominal pain—Dapsone—leprosy	0.002	0.00383	CcSEcCtD
Darunavir—Body temperature increased—Dapsone—leprosy	0.002	0.00383	CcSEcCtD
Darunavir—Renal failure—Thalidomide—leprosy	0.00199	0.00382	CcSEcCtD
Darunavir—Myocardial infarction—Thalidomide—leprosy	0.00199	0.00381	CcSEcCtD
Darunavir—Neuropathy peripheral—Thalidomide—leprosy	0.00199	0.00381	CcSEcCtD
Darunavir—Stomatitis—Thalidomide—leprosy	0.00198	0.00379	CcSEcCtD
Darunavir—Haematuria—Thalidomide—leprosy	0.00193	0.00371	CcSEcCtD
Darunavir—Epistaxis—Thalidomide—leprosy	0.00191	0.00367	CcSEcCtD
Darunavir—Bradycardia—Thalidomide—leprosy	0.00185	0.00355	CcSEcCtD
Darunavir—Hepatitis—Thalidomide—leprosy	0.00182	0.00349	CcSEcCtD
Darunavir—Hypoaesthesia—Thalidomide—leprosy	0.00181	0.00347	CcSEcCtD
Darunavir—Urinary tract disorder—Thalidomide—leprosy	0.0018	0.00345	CcSEcCtD
Darunavir—Oedema peripheral—Thalidomide—leprosy	0.00179	0.00344	CcSEcCtD
Darunavir—Urethral disorder—Thalidomide—leprosy	0.00178	0.00342	CcSEcCtD
Darunavir—Visual impairment—Thalidomide—leprosy	0.00175	0.00336	CcSEcCtD
Darunavir—Erythema multiforme—Thalidomide—leprosy	0.00172	0.0033	CcSEcCtD
Darunavir—Eye disorder—Thalidomide—leprosy	0.0017	0.00326	CcSEcCtD
Darunavir—Cardiac disorder—Thalidomide—leprosy	0.00169	0.00324	CcSEcCtD
Darunavir—Angiopathy—Thalidomide—leprosy	0.00165	0.00317	CcSEcCtD
Darunavir—Immune system disorder—Thalidomide—leprosy	0.00164	0.00315	CcSEcCtD
Darunavir—Mediastinal disorder—Thalidomide—leprosy	0.00164	0.00315	CcSEcCtD
Darunavir—Chills—Thalidomide—leprosy	0.00163	0.00313	CcSEcCtD
Darunavir—Alopecia—Thalidomide—leprosy	0.00161	0.00309	CcSEcCtD
Darunavir—Vomiting—Dapsone—leprosy	0.00161	0.00308	CcSEcCtD
Darunavir—Mental disorder—Thalidomide—leprosy	0.0016	0.00306	CcSEcCtD
Darunavir—Malnutrition—Thalidomide—leprosy	0.00159	0.00304	CcSEcCtD
Darunavir—Headache—Dapsone—leprosy	0.00158	0.00304	CcSEcCtD
Darunavir—Flatulence—Thalidomide—leprosy	0.00156	0.003	CcSEcCtD
Darunavir—Dysgeusia—Thalidomide—leprosy	0.00155	0.00298	CcSEcCtD
Darunavir—Muscle spasms—Thalidomide—leprosy	0.00152	0.00292	CcSEcCtD
Darunavir—Nausea—Dapsone—leprosy	0.0015	0.00288	CcSEcCtD
Darunavir—Ill-defined disorder—Thalidomide—leprosy	0.00147	0.00282	CcSEcCtD
Darunavir—Anaemia—Thalidomide—leprosy	0.00147	0.00281	CcSEcCtD
Darunavir—Agitation—Thalidomide—leprosy	0.00146	0.00279	CcSEcCtD
Darunavir—Angioedema—Thalidomide—leprosy	0.00145	0.00278	CcSEcCtD
Darunavir—Malaise—Thalidomide—leprosy	0.00143	0.00274	CcSEcCtD
Darunavir—Vertigo—Thalidomide—leprosy	0.00142	0.00273	CcSEcCtD
Darunavir—Syncope—Thalidomide—leprosy	0.00142	0.00273	CcSEcCtD
Darunavir—Leukopenia—Thalidomide—leprosy	0.00142	0.00272	CcSEcCtD
Darunavir—Palpitations—Thalidomide—leprosy	0.0014	0.00269	CcSEcCtD
Darunavir—Loss of consciousness—Thalidomide—leprosy	0.00139	0.00267	CcSEcCtD
Darunavir—Cough—Thalidomide—leprosy	0.00138	0.00265	CcSEcCtD
Darunavir—Convulsion—Thalidomide—leprosy	0.00137	0.00263	CcSEcCtD
Darunavir—Hypertension—Thalidomide—leprosy	0.00137	0.00262	CcSEcCtD
Darunavir—Arthralgia—Thalidomide—leprosy	0.00135	0.00259	CcSEcCtD
Darunavir—Chest pain—Thalidomide—leprosy	0.00135	0.00259	CcSEcCtD
Darunavir—Myalgia—Thalidomide—leprosy	0.00135	0.00259	CcSEcCtD
Darunavir—Anxiety—Thalidomide—leprosy	0.00134	0.00258	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00134	0.00257	CcSEcCtD
Darunavir—Discomfort—Thalidomide—leprosy	0.00133	0.00256	CcSEcCtD
Darunavir—Dry mouth—Thalidomide—leprosy	0.00132	0.00253	CcSEcCtD
Darunavir—Confusional state—Thalidomide—leprosy	0.0013	0.0025	CcSEcCtD
Darunavir—Shock—Thalidomide—leprosy	0.00127	0.00244	CcSEcCtD
Darunavir—Nervous system disorder—Thalidomide—leprosy	0.00127	0.00243	CcSEcCtD
Darunavir—Thrombocytopenia—Thalidomide—leprosy	0.00127	0.00243	CcSEcCtD
Darunavir—Tachycardia—Thalidomide—leprosy	0.00126	0.00242	CcSEcCtD
Darunavir—Skin disorder—Thalidomide—leprosy	0.00126	0.00241	CcSEcCtD
Darunavir—Hyperhidrosis—Thalidomide—leprosy	0.00125	0.0024	CcSEcCtD
Darunavir—Anorexia—Thalidomide—leprosy	0.00123	0.00236	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Thalidomide—leprosy	0.00118	0.00226	CcSEcCtD
Darunavir—Insomnia—Thalidomide—leprosy	0.00117	0.00224	CcSEcCtD
Darunavir—Paraesthesia—Thalidomide—leprosy	0.00116	0.00223	CcSEcCtD
Darunavir—Dyspnoea—Thalidomide—leprosy	0.00115	0.00221	CcSEcCtD
Darunavir—Somnolence—Thalidomide—leprosy	0.00115	0.00221	CcSEcCtD
Darunavir—Dyspepsia—Thalidomide—leprosy	0.00114	0.00218	CcSEcCtD
Darunavir—Decreased appetite—Thalidomide—leprosy	0.00112	0.00216	CcSEcCtD
Darunavir—Gastrointestinal disorder—Thalidomide—leprosy	0.00112	0.00214	CcSEcCtD
Darunavir—Fatigue—Thalidomide—leprosy	0.00112	0.00214	CcSEcCtD
Darunavir—Constipation—Thalidomide—leprosy	0.00111	0.00212	CcSEcCtD
Darunavir—Pain—Thalidomide—leprosy	0.00111	0.00212	CcSEcCtD
Darunavir—Feeling abnormal—Thalidomide—leprosy	0.00107	0.00204	CcSEcCtD
Darunavir—Gastrointestinal pain—Thalidomide—leprosy	0.00106	0.00203	CcSEcCtD
Darunavir—Urticaria—Thalidomide—leprosy	0.00103	0.00197	CcSEcCtD
Darunavir—Body temperature increased—Thalidomide—leprosy	0.00102	0.00196	CcSEcCtD
Darunavir—Abdominal pain—Thalidomide—leprosy	0.00102	0.00196	CcSEcCtD
Darunavir—Hypersensitivity—Thalidomide—leprosy	0.000953	0.00183	CcSEcCtD
Darunavir—Asthenia—Thalidomide—leprosy	0.000928	0.00178	CcSEcCtD
Darunavir—Pruritus—Thalidomide—leprosy	0.000915	0.00176	CcSEcCtD
Darunavir—Diarrhoea—Thalidomide—leprosy	0.000885	0.0017	CcSEcCtD
Darunavir—Dizziness—Thalidomide—leprosy	0.000855	0.00164	CcSEcCtD
Darunavir—Vomiting—Thalidomide—leprosy	0.000823	0.00158	CcSEcCtD
Darunavir—Rash—Thalidomide—leprosy	0.000816	0.00156	CcSEcCtD
Darunavir—Dermatitis—Thalidomide—leprosy	0.000815	0.00156	CcSEcCtD
Darunavir—Headache—Thalidomide—leprosy	0.00081	0.00155	CcSEcCtD
Darunavir—Nausea—Thalidomide—leprosy	0.000768	0.00147	CcSEcCtD
